/ Unknown status临床1/2期IIT A phase 1/2 study investigating the pharmacokinetics, safety and efficacy of a highly concentrated buccal formulation of apomorphine (APORON®) in subjects with Parkinson's Disease - Buccal apomorphine (APORON) administration
100 项与 Criceto IKM B.V. 相关的临床结果
0 项与 Criceto IKM B.V. 相关的专利(医药)
100 项与 Criceto IKM B.V. 相关的药物交易
100 项与 Criceto IKM B.V. 相关的转化医学